Schizophrenia and bipolar disorder (BPD) are common neurodevelopmental disorders, characterized by various life-crippling symptoms and high suicide rates. Multiple studies support a strong genetic involvement in the etiology of these disorders, although patterns of inheritance are variable and complex. Adenosine-to-inosine RNA editing is a cellular mechanism, which has been implicated in mental disorders and suicide. To examine the involvement of altered RNA editing in these disorders, we: (i) quantified the mRNA levels of the adenosine deaminase acting on RNA (ADAR) editing enzymes by real-time quantitative polymerase chain reaction, and (ii) measured the editing levels in transcripts of several neuroreceptors using 454 high-throughput sequencing, in dorsolateral -prefrontal cortices of schizophrenics, BPD patients and controls. Increased expression of specific ADAR2 variants with diminished catalytic activity was observed in schizophrenia. Our results also indicate that the I/V editing site in the glutamate receptor, ionotropic kainate 2 (GRIK2) transcript is under-edited in BPD (type I) patients (45.8 versus 53.9%, P 5 0.023). GRIK2 has been implicated in mood disorders, and editing of its I/V site can modulate Ca 12 permeability of the channel, consistent with numerous observations of elevated intracellular Ca 12 levels in BPD patients. Our findings may therefore, at least partly, explain a molecular mechanism underlying the disorder. In addition, an intriguing correlation was found between editing events on separate exons of GRIK2. Finally, multiple novel editing sites were detected near previously known sites, albeit most with very low editing rates. This supports the hypothesis raised previously regarding the existence of wide-spread low-level 'background' editing as a mechanism that enhances adaptation and evolvability.
INTRODUCTION
Schizophrenia and bipolar disorder (BPD) are common neurodevelopmental disorders, with a combined occurrence rate of 4% worldwide. They are characterized by myriads of lifecrippling symptoms, most commonly delusions and hallucinations in schizophrenia, and extreme mood swings in BPD, affecting patients as well as their families. In addition, both disorders are characterized by high suicide rates. Family, adoption and twin studies all support a strong genetic influence, although patterns of inheritance are variable and complex. The genetic factors conferring susceptibility to these disorders have largely remained elusive, as only a small number of genetic variants, contributing modest effects, have been identified.
RNA editing is a cellular mechanism, which may alter the composition and properties of proteins (1 -5) , affect splicing (6) as well as regulate gene expression and cellular localization of transcripts (7) . A common type of RNA editing involves the conversion of adenosine (A) to inosine (I) by adenosine deaminase acting on RNA (ADAR) 1 and ADAR2, where inosine acts as guanosine during cellular processes (8, 9) . Interestingly, the ADAR2 gene itself is located in a chromosomal region, 21q22, previously linked to familial BPD in several independent studies (10 -15) . Adenosine-to-inosine (A-to-I) editing at several targets has been implicated in mental disorders: decreased editing of the ionotropic a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 2 glutamate receptor subunit (GRIA2) in schizophrenia has been reported (16) ; alterations in RNA editing efficiency of the serotonin receptor 5-HT 2C R were found in brains of individuals with major depression (17) , particularly those of which who committed suicide (18, 19) , albeit not quite so in schizophrenia (18) (19) (20) (21) (22) and BPD patients (18, 21) ; mice treated with the antidepressant drug fluoxetine (Prozac) displayed changes in the editing of several sites on 5-HT 2C R, exactly opposite to those seen in suicide victims (17) (18) (19) 23, 24) , and selective changes induced by antidepressant drugs in the editing of AMPA-kainate receptor subunits were observed (25) . These findings suggest that one of the roles of antipsychotic drugs may be the reversal of abnormal editing seen in patients. In this study, we thoroughly examined the involvement of A-to-I RNA editing in psychiatric disorders by using a combined approach: quantification of ADARs expression levels, as well as editing levels within neuroreceptor subunits, in brain samples obtained from patients and controls. Neuroreceptor genes, which have not been examined previously in this context, were selected for analysis based on their relevance to the etiology of schizophrenia and BPD. To reduce potential endogenous variation among diagnostic subgroups, only BPD type I (BPD I) was included in comparative analyses. BPD I is the most common, and easily diagnosed subtype of BPD. We found that the expression of ADAR transcripts is clustered into two general arms of regulation, and that specific transcripts are deregulated in schizophrenia. In addition, decreased editing was observed at a specific protein recoding site in GRIK2. Editing patterns of multiple sites in GRIK2 were identified, and editing events on separate exons were found to be strongly coupled, suggesting hitherto unknown mechanisms for how a transcript is edited in vivo. Finally, in all samples, multiple novel editing sites were detected in vicinity to the known sites.
RESULTS

Expression analysis of ADARs: the editing enzymes
To determine whether the ADAR enzymes are deregulated in schizophrenia and/or BPD, a real-time quantitative polymerase chain reaction (qPCR) expression analysis was performed. Initially, the levels of pan (total) -ADAR1 and two of its RefSeq (NCBI Reference Sequence) variants, pan-ADAR2 and five of its RefSeq transcripts ( Fig. 1 ), and ADAR3 (accession ID: NM_018702) were quantified by relative qPCR. ADAR1-B and pan-ADAR2 levels were found to weakly correlate with brain pH, a factor considered as a predictor for RNA quality (26) (r ¼ 0.336, P ¼ 0.002 and r ¼ 0.360, P ¼ 0.001, respectively). No effects of age, gender, smoking, substance abuse, postmortem interval or refrigeration interval were observed. Increased expression of the deficient ADAR2 variant (1.37-fold, P ¼ 0.001) and of ADAR3 (1.16-fold, P ¼ 0.005) was observed in suicide victims (n ¼ 17) compared with individuals who did not commit suicide (n ¼ 68). The expression levels of ADAR1-B, pan-ADAR2 and ADAR3 were found to be significantly increased in schizophrenia patients (n ¼ 26) compared with controls (n ¼ 29), while no differential expression was observed in BPD I patients (n ¼ 23) in any of the transcripts examined ( Fig. 2 ). It can be noticed that the increased expression of pan-ADAR2 in schizophrenia is primarily driven by the levels of deficient ADAR2 (bottom, center), and the ADAR2 transcript with Alu insert (bottom, left), although the expression of these variants is not significantly altered due to large variation in the schizophrenia group. Interestingly, both of these transcripts are known to code for proteins with reduced catalytic activity (27) .
The onset age of schizophrenia is moderately correlated with the expression of ADAR1-A (r ¼ 0.395, P ¼ 0.046, n ¼ 26), and ADAR3 (r ¼ 0.455, P ¼ 0.02, n ¼ 26). No correlations were observed with BPD onset age. In order to examine the expressional relationships among all ADAR transcripts, which may reflect the nature of their regulatory relationships, a cluster analysis was performed. It revealed that while the BPD and the control group had identical clusters, those of the schizophrenia group slightly differed. In the control and BPD groups, ADAR1-A was assigned to a separate group alone, in schizophrenia it was ADAR1-B instead ( Fig. 3 , data for BPD are not shown). Altogether, two general expression clusters were observed: one containing non-deficient and Alu-lacking ADAR2 transcripts (accession ID: NM_001112), and the other containing all the other transcripts (and possibly a third cluster containing ADAR1-A). This indicates that at least two separate A-to-I editing machineries exist, which are regulated independently and may have different roles.
RNA editing rates
To accurately quantify the editing levels of multiple sites in multiple samples simultaneously, we amplified sequences flanking seven known editing targets in six genes coding for neuroreceptor subunits: GRIA2 -4, GRIK1 -2 and GABRA3 (refseq accession numbers are shown in Supplementary Material, Table S2 ). All targets were amplified in 60 samples (20 of each clinical group), and the amplicons were submitted to 454 high-throughput sequencing (Materials and Methods). More than 278 000 reads were obtained, with a median length of Figure 1 . Illustrations of ADAR1 and ADAR2, and their splice variants. ADAR1-A (accession ID: NM_001111) is also named after its long protein product, p150. ADAR1-B (accession ID: NM_001025107) and C (accession ID: NM_001193495) differ in their first exon, and are identical in protein sequence (p110). ADAR2 is capable of undergoing auto-editing (indicated upstream to exon 4), which leads to a premature stop codon. An Alu cassette is alternatively spliced into the ADAR2 mRNA in the deaminase domain (accession ID: NM_015833). Activation of a cryptic splice site in the 3 ′ exon of ADAR2 (shown in the bottommost transcript) leads to a truncated protein (accession ID: NM_001160230) with diminished activity (27) . Notably, all combinations of alternative events may exist in a single mature ADAR2 transcript.
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Human Molecular Genetics, 2012, Vol. 21, No. 2 236 nt. As a proof of concept for the two-step PCR sample labeling strategy used, one sample was divided into three aliquots, and each was labeled with a different primer tag. These were subsequently sequenced and analyzed separately. Editing at the intronic site '21' of ADAR2 was quantified by absolute qPCR, as described in Materials and Methods. The estimated editing rates showed high reproducibility (Supplementary Material, Fig. S1 ). All AMPA receptor genes contain an alternative-splicing cassette, where two exons (named 'flop' and 'flip') are spliced in a mutually exclusive manner. The reads obtained from the 454 sequencing for the AMPA receptors allowed to distinguish between their two splice variants. Therefore, the editing rates could also be calculated for each variant separately. The mean editing rates measured in the different targets in each clinical group are shown in Table 1 . To facilitate high accuracy of editing level estimates, only samples with .100 reads, and with 95% confidence interval ≤10% for the observed editing rate, were included in quantitative analyses (referred to as 'informative samples').
A moderate correlation was observed between the editing level of site 'R764G' in GRIA2 and brain pH, (r ¼ 0.51, P ¼ 0.008, n ¼ 26). No significant correlations of editing levels were observed with age at death, postmortem interval or sample refrigeration interval. A gender effect was observed in the editing level of site G615G in GRIK2 (P ¼ 0.003), which was more highly edited in males (19.7 + 3.2%, n ¼ 20) than in females (15.6 + 2.4%, n ¼ 8).
Altogether, the average editing levels were tightly conserved within and between clinical groups. However, they significantly differed for site I567V in GRIK2, which was under-edited in BPD-I patients (ANOVA P ¼ 0.06, post hoc P ¼ 0.023, Fig. 4 ). G615G editing levels did not differ significantly among clinical groups when adjusted for gender [general linear model (GLM) gender effect P ¼ 0.015, status group effect P ¼ 0.11]. Paired t-tests performed to examine the difference in editing levels between 'flip' and 'flop' splice products, revealed a small, but significant difference in GRIA3, and a strikingly large difference in GRIA4 ( Table 2 ). The only site whose editing level was correlated between these variants was site R764G in GRIA2 (r ¼ 0.826, P ¼ 0.001). Correlation analysis between editing rates and ADAR transcripts expression indicated that the editing of site R765G in GRIA4 is correlated with most ADAR2 isoforms and with ADAR3, but not with any of the ADAR1 isoforms ( Table 3) . ADAR2 editing at site '21' [reflecting the ratio of truncated products ( Fig. 1 )] is correlated with the editing of site R765G in GRIA4. It also shows that site R764G in GRIA2 is correlated with ADAR1-B.
Editing patterns in GRIK2
Since GRIK2 harbors several sites that are edited frequently, we aimed to examine the contents and distribution of editing patterns within its transcripts. Thus, all editing patterns of sites with mean editing rate .1% were identified and quantified. The sites that met this criterion were: I567V, Y571C, G615G, M620V, Q621R. The name format used for representing patterns composed by these sites contains the letter 'P' followed by five binary digits, each representing a corresponding editing site (e.g. p01000 is the pattern in which only site 'Y571C' is edited, and the other sites are unedited). Out of the 32 possible combinations, 25 different patterns were observed (Supplementary Material, Table S1 ). Only eight patterns had a frequency .1%, which together accounted for .95% of the reads (Fig. 5 ). No significant difference was observed between the pattern distributions of the different groups (x 2 -test P ¼ 0.92). However, the frequencies of patterns p01001 (where I567V is unedited) and p11101 (I567V is edited) revealed trends for increased (1.24-fold, t-test P ¼ 0.036) and decreased (1.21-fold, t-test P ¼ 0.054) representation, respectively, in BPD-I patients compared with control subjects. The most common pattern with only one edited site is the one in which Q621R is singly edited (p00001, 6.64% of all transcripts), indicating that this is the site where editing initiates (principal site) in GRIK2. The next common pattern with only one edited site is the one in which Y571C is singly edited (p01000, 3.37% of all transcripts). This site is located on the upstream exon, and may act as an independent principal site in that exon. Of note is that each of these sites is the most 3 ′ proximal in the exon. The rest of the patterns with a singly edited site are very rare (p10000, p00100 and p00010 together: 0.58% of all transcripts).
Coupling and clustering of editing sites
To examine the degree of interdependence among different editing sites within transcripts, we analyzed the correlations between pairs of sites with a median editing rate .1% ( Table 4 ). The analyses were based on reads obtained from all samples, except for GRIK2 analyses, which were performed only on reads obtained from control samples. Bonferroni correction was applied for multiple testing (n ¼ 15), and the corrected critical value corresponding to P ¼ 0.0033 with d.f. ¼ 1 was x 2 ¼ 8.62. A certain overlap was observed with the findings of Ensterö et al. (2009) (28), where most sites within 1 -4 nt (where the principal site is downstream) were coupled, as well as site pairs with 13 nt distance. In addition, pairs with 17 nt distance were coupled. Surprisingly, all the pairs tested in GRIK2 were coupled, including those separated by an intron (.30 000 nt long). In order to examine the relationship among several sites simultaneously, a cluster analysis was performed ( Fig. 6 ). No differences in the clustering were observed among the different clinical groups. In agreement with the coupling analysis results, sites Y571C and Q621R were assigned to the same class with a very close Euclidean proximity, despite the fact that they are located in separate exons. Site I567V was assigned to a separate class, but relatively within close proximity to the aforementioned sites. G615G and M620V were assigned to another class, very distant from the other sites.
Identification of novel editing sites
Aligning the 454 reads to the reference sequences revealed a number of previously unknown A-to-I editing sites, which were edited at a rate higher than 1% (highlighted rows in Figure 1 . n, sample size. ADAR2NoAlu, ADAR2 transcript lacking an Alu cassette. ADAR2NnDef, ADAR2 non-deficient transcript. ADAR2Def, ADAR2-deficient transcript. ADAR2Alu, ADAR2 transcript containing an alu cassette.
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Human Molecular Genetics, 2012, Vol. 21, No. 2 Table 1 ). Sanger sequencing was used to validate some of these sites, and an example chromatogram is shown in Supplementary Material, Figure S2 . In addition, numerous rare editing events were detected, which occur in ,1% of the transcripts. In order to filter out potential sequencing errors, the AmpliconNoise software package (29) was used (as detailed in Materials and Methods), which is dedicated to removal of noise from 454 sequenced PCR amplicons. A criterion was set to help identify true editing/mismatch occurrences, by which an occurrence that survived AmpliconNoise cleanup was considered true only if it was found in several independent samples. This was based on the rationale that a mismatch that persists in multiple samples, which underwent PCR amplification and (pyro)sequencing reactions independently, is more likely to be a true event. Thus, for a cutoff of minimum five samples, 839 mismatches were found (Supplementary Material, Table S2 ). Since the sum of lengths of all amplicons sequenced in this study (excluding primers and including flip/flop exons) was 1665 nt, the average mismatch rate is astoundingly high [0.504 per base (or 1 mismatch every 1.98 bases)]. Mismatches that may be attributed to known RNA editing mechanisms (i.e. A G and C T) accounted together for 49% of the mismatches. However, surprisingly, 33.6% of the mismatches were T C, and 14.2% were G A ( Fig. 7) , events which cannot be explained by any known editing mechanism. When a harsher filtering criterion was applied, by which mismatches were retained if they were present in at least half of the informative samples, 176 mismatches remained. Nevertheless, the distribution of mismatch types did not differ dramatically. A G and C T mismatches together accounted for 50% of the data, but the relative frequencies of both A G and T C mismatches exceeded 40% each ( Supplementary Material, Fig. S3 ), a clear enrichment compared with the expected rate of 8.3% under the null hypothesis (P , 2.2e216 in data sets with both filtering criteria). A G mismatches (or editing events) as well as non-A G mismatches appear to be spread throughout the entire exon harboring the principal editing site, and are also found in neighboring exons. No preferences for their location relative to the principal site were observed ( Supplementary Material, Fig. S4 ).
Identification of novel transcript variants
Several novel splicing variants of the GRIA genes were detected among the reads obtained from the high-throughput amplicon sequencing. Those that were long enough to meet the GeneBank criteria were submitted to the database and were assigned accession numbers: JN547407 (GRIA4 novel transcript) and JN547408 (GRIA2 novel transcript).
DISCUSSION
In the present study, multiple novel sites that undergo editing were detected in the vicinity of previously known sites, albeit most with very low editing rates (,1%) ( Fig. 7 ; Supplementary Material, Table S2 and Fig. S2 ). A marked enrichment was observed for A G mismatches, which can be attributed to A-to-I editing, but also for T C mismatches, for which no editing mechanism is known. It should be noted that this type of mismatch has been observed in mRNA transcripts previously by Levanon (32) . In agreement with our results, these findings were enriched for the same two types of mismatches: A G and T C. Nevertheless, since amplicon high-throughput sequencing was utilized in our study, it provided a much deeper coverage than RNA-seq, and thus allowed for detection of rare mismatches that appear to occur in numerous positions. Whether these events occurr more frequently in genes that are targeted for high-level editing is therefore yet to be determined. Interestingly, Gommans et al. (33) estimated that low-level 'background' editing is likely to be a wide-spread phenomenon. They postulated that during environmental changes, some rare edited transcripts could fulfill a critical function, resulting in acclimatization and survival advantage of the organism, and lead to adaptation (33) . While the identification of novel sites confirms the primary stage of this hypothesis, a more extensive sequence analysis is required to detect DNA polymorphisms that affect RNA editing, which may facilitate fixation of a specific editing pattern under selective conditions. The image that emerges from the ADAR expression analysis reflects an increased transcription of ADAR1-B and of transcripts with little, or no catalytic activity in schizophrenia. Cluster analysis shows that all of the deregulated transcripts are part of one regulatory arm. The fact that no over-editing of any of the quantified targets was observed in schizophrenia is therefore not surprising, due to the diminished or lack of catalytic activity of the transcripts with increased expression. In fact, it was proposed that ADAR3 has an inhibitory effect on editing (8, 34) and ADAR1-B was demonstrated to inhibit catalytic activity upon heterodimerization with ADAR2 (35). Thus, our data suggest that ADAR1 transcript expression is co-regulated with the expression of inactive/inhibitive ADARs, which may act coordinately and distinctly from fully-catalytic ADAR2 variants. This may be manifested in differential preferences for interaction with RNA substrates, or for dimerization with other ADAR variants. In addition, the present study indicates that the absence of correlation observed previously between ADAR expression and editing levels (35) (36) (37) cannot be attributed to the presence of inactive ADAR variants, since a correlation with active ADAR variants is still absent. Other factors besides ADARs expression levels can potentially affect changes in editing rates. These may include availability of inositol hexaphosphate (IP6), an ADAR co-factor (38), substrate abundance (8, 36) and particularly spatial-temporal availability and/or accessibility of ADARs to their substrates (Wahlstedt and Ö hman, unpublished data).
In addition to the increased levels of specific ADAR variants in schizophrenia, it was also noticed that overall the variance in expression levels and editing levels was highest in this patient group (Table 1, Figs 2 and 4) . This observation may be explained by etiological heterogeneity among individuals 
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Human Molecular Genetics, 2012, Vol. 21, No. 2 diagnosed with schizophrenia, which may argue in favor of the view that schizophrenia is infact a group of different syndromes, with some overlapping pathophysiologies. However, it is also possible that this large variance reflects an upstream regulatory malfunction in patients, whereby the capacity to maintain steady expression levels is lost. Nevertheless, it should be noted that the overall strikingly high degree of conservation in editing levels (sometimes with the exception of schizophrenia) indicates a functional importance of maintaining accurate editing levels in these targets. Intriguingly, GRIA4 was the only AMPA subunit whose R/G editing levels differed substantially between its 'flop' and 'flip' variants (Table 3 ). While the exon sequences of AMPA genes are highly conserved (39) , their introns in the region flanking the 'flop' and the 'flip' exons vary both in sequence and in length. Downstream intronic sequences have been demonstrated to play a key role in the catalysis of A-to-I editing (40, 41) . It can therefore be speculated that in GRIA4 such an element lies in the intron downstream 'flop' and upstream 'flip', which is removed from the pre-mRNA at a later splicing event upon 'flop' retention, compared with 'flip' retention.
This may facilitate a longer time frame for the catalysis of deamination at the R/G site in 'flop' pre-mRNAs. The coupling and clustering of editing events in separate exons of GRIK2 may also provide a clue for the involvement of distant downstream introns in the catalysis of A-to-I editing. Further study is warranted to assess whether the intronic element that is required for editing the Q/R site (41) is also required for editing the upstream exon (sites I567V and Y571C). It may also allow to determine whether removal of the intron between these two exons is a prerequisite for their splicing.
It should be noted that the results indicating under-editing of the I/V site of GRIK2 in BPD I patients should be interpreted cautiosly, due to the small number of informative samples included in this analysis. Nevertheless, the reliability of these results may be supported by the near-'all or none' effect (almost all bipolar samples have lower editing than almost all of the control samples), as shown in Figure 4 . Highresolution studies, examining the editing level at this position in other samples or brain regions, are thus warranted. Interestingly, GRIK2 has been previously implicated in mood disorders. It was shown to play a role in controlling abnormalities related to the behavioral symptoms of mania (42) , and reduced GRIK2 expression has been observed in brains from bipolar patients (43) (44) (45) . The amino acid coded by the I/V editing site in GRIK2 is located in trans-membrane domain 1 of the receptor subunit. Editing of this position has been shown to fine-tune the Ca +2 permeability of the channel; specifically, its edited form contributed to a decrease in Ca +2 permeability most pronouncely in channels containing an unedited Q/R site (in TM2) (46) . Abnormally low editing in the I/V position may result in increased Ca +2 influx via the GRIK2 channel. This is consistent with the numerous observations of elevated intracellular Ca +2 levels in platelets, lymphocytes or neutrophils of patients with BPD, and could be additive to the abnormal Ca +2 metabolism seen in patients (47 and references therein). Interestingly, decreased mRNA levels of the calcium binding protein parvalbumin were observed in the entorhinal cortex of BPD subjects (48) , and also in GABA neuron subpopulations in the dorsolateral -prefrontal cortex (DLPFC) (49) . In addition, deficits have been found in parvalbumincontaining interneurons in the hippocampus of BPD patients (50) . It is therefore conceivable that these deficits occur also in GRIK2-expressing interneurons, where a seemingly small reduction in the editing levels could results in an increase in cellular calcium levels. Significant correlations are highlighted and in bold. r, Pearson's correlation coefficient. P, two-tail significance. n, sample size. Only lines with a significant correlation are included in the matrix. (26) . Briefly, tissue was homogenized in Trizol; nucleic acids were separated with chloroform at highspeed centrifugation; RNA was then precipitated with isopropyl alcohol and washed with 70% alcohol. Pellets of RNA were resuspended in DEPC water. GAPDH mRNA levels were measured by reverse transcription (RT) PCR. mRNA Table S3 .
Sample preparation for high-throughput sequencing
To keep track of the human sample identities, targets were amplified using tagged primers in a two-step PCR strategy, which also allowed to minimize the total number of primers required ( Supplementary Material, Fig. S5 ). The primers were designed using Primer 3.0 [http://frodo.wi.mit.edu/, Table S4 . PCR products were purified from 2.5% agarose gels using the Zymoclean TM Gel DNA Recovery Kit (Zymo Research), and their concentrations were measured by the NanoDrop w ND-1000 Spectrophotometer (Thermo Fisher Scientific). Five nanograms of each PCR product were submitted for deep-sequencing by the Roche 454 genome sequencer FLX system at the Royal Institute of Technonogy (KTH), Stockholm, Sweden, using a two-region kit.
High-throughput sequencing output analysis
The Megablast program within Blast v2.2.24 was used for aligning reads to the reference sequences and scoring them with the parameters: -W 16 -F F -r 1 -q -2 -G 2 -E 1. Perl codes (v5.8.8) were written utilizing BioPerl 1.6.1 libraries (54) to assign sample identities to the output reads, parse Blast alignment output, detect editing/mismatch positions and calculate their frequencies. The AmpliconNoise (v1.24) software package (29) was used to remove pyrosequencing noise from the 454 reads, as follows: prior to 454 denoising, 454 flowgrams are truncated at the first low-quality quartet of flows or at the 360th flow. Shorter reads are discarded. The subsequent 454 denoising process determines the probability of a read belonging to a real sequence by applying empirical 454 sequencing error distributions. This generally reduces the number of unique reads. The total number of reads is unaffected, since all reads are assigned to one unique sequence. A similar process for PCR error cleanup resulted in the removal of numerous reads that contained mismatches in known editing sites, and was thus unsuitable for our data and was not used.
Statistical analyses
Normality of mRNA expression data distribution was evaluated by Q -Q plots, made by the SPSS 15.0 program (SPSS, Chicago, IL, USA). Transcripts whose expression levels did not distribute normally underwent linear transformation. Thus, ADAR1-A, ADAR1-B, 'ADAR2 with alu', 'ADAR2 deficient' and ADAR3 expression were log-transformed, and 'ADAR2 non-deficient' expression was square-root-transformed prior to data analysis to achieve normal distribution. The GLM was applied to correct for epidemiological effects when necessary. Confidence intervals for binomial data generated by deep-sequencing were constructed by Wilson's approximation (55) . For probabilities (P^) .0.99 or ,0.01 the Agresti -Coull interval (56) was used due to the poor coverage of the Wilson interval in these ranges (57) . Coupling analysis was performed by x 2 tests with Yate's continuity correction using the R programming environment (www.R-project.org). Clustering analyses were performed by the Excel add-in, XL-STAT (Microsoft), where the Eucledian distance was calculated.
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